These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21076447)

  • 21. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR.
    Phisitkul S; Khanna A; Simoni J; Broglio K; Sheather S; Rajab MH; Wesson DE
    Kidney Int; 2010 Apr; 77(7):617-23. PubMed ID: 20072112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of metabolic acidosis in patients with chronic kidney disease (CKD)].
    Dębowska M; Przedlacki J
    Wiad Lek; 2017; 70(6 pt 2):1197-1200. PubMed ID: 29533913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Continuum of Acid Stress.
    Wesson DE
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1292-1299. PubMed ID: 33741720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alkaline Diet and Metabolic Acidosis: Practical Approaches to the Nutritional Management of Chronic Kidney Disease.
    Rodrigues Neto Angéloco L; Arces de Souza GC; Almeida Romão E; Garcia Chiarello P
    J Ren Nutr; 2018 May; 28(3):215-220. PubMed ID: 29221627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney Response to the Spectrum of Diet-Induced Acid Stress.
    Goraya N; Wesson DE
    Nutrients; 2018 May; 10(5):. PubMed ID: 29751620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD.
    Raphael KL
    J Am Soc Nephrol; 2018 Feb; 29(2):376-382. PubMed ID: 29030467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional renal reserve capacity in different stages of chronic kidney disease.
    Barai S; Gambhir S; Prasad N; Sharma RK; Ora M
    Nephrology (Carlton); 2010 Apr; 15(3):350-3. PubMed ID: 20470306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
    Jain AK; Cuerden MS; McLeod I; Hemmelgarn B; Akbari A; Tonelli M; Quinn RR; Oliver MJ; Garg AX
    Kidney Int; 2012 Jun; 81(12):1248-53. PubMed ID: 22437415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of the Endocrine System in the Regulation of Acid-Base Balance by the Kidney and the Progression of Chronic Kidney Disease.
    Nagami GT; Kraut JA
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of endothelin-1 in renal regulation of acid-base equilibrium in acidotic humans.
    Pallini A; Hulter HN; Muser J; Krapf R
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F991-9. PubMed ID: 22859405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acid Base Balance and Progression of Kidney Disease.
    Chen W; Levy DS; Abramowitz MK
    Semin Nephrol; 2019 Jul; 39(4):406-417. PubMed ID: 31300095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention.
    Wesson DE; Jo CH; Simoni J
    Kidney Int; 2012 Dec; 82(11):1184-94. PubMed ID: 22832514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate.
    Agarwal R; Hynson JE; Hecht TJ; Light RP; Sinha AD
    Kidney Int; 2011 Nov; 80(10):1073-9. PubMed ID: 21716260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reporting the eGFR and its implication for CKD diagnosis.
    Botev R; Mallié JP
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1606-7. PubMed ID: 18922981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral treatment of metabolic acidosis in hemodialyzed patients and the implications on the hemodynamic status.
    Checheriţă IA; David C; Ciocâlteu A; Lascăr I; Budală L
    Rom J Morphol Embryol; 2013; 54(3):539-43. PubMed ID: 24068401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bicarbonate therapy for prevention of chronic kidney disease progression.
    Łoniewski I; Wesson DE
    Kidney Int; 2014 Mar; 85(3):529-35. PubMed ID: 24107852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy.
    Mahajan A; Simoni J; Sheather SJ; Broglio KR; Rajab MH; Wesson DE
    Kidney Int; 2010 Aug; 78(3):303-9. PubMed ID: 20445497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acid Balance, Dietary Acid Load, and Bone Effects-A Controversial Subject.
    Frassetto L; Banerjee T; Powe N; Sebastian A
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29690515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances in detection, evaluation and management of chronic kidney disease].
    Indridason OS; Thorsteinsdóttir I; Pálsson R
    Laeknabladid; 2007 Mar; 93(3):201-7. PubMed ID: 17341799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.